1. Please check and comment entries here.
Table of Contents

    Topic review

    Cyclodextrin Multicomponent Complexes: Pharmaceutical Applications

    View times: 19
    Submitted by: Marcela Longhi
    (This entry belongs to Entry Collection "Biopharmaceuticals Technology ")

    Definition

    Cyclodextrins (CD) are a family of macromolecules obtained by enzymatic degradation of starch. Their structure resembles a truncated cone, with a somewhat lipophilic central cavity and an external hydrophilic surface.  Due to these characteristics the pharmaceutical applications are mostly related to the ability of CDs to form inclusion complexes, formed by interactions between guest (drug) and host (CD) molecules, and they have the ability to modulate several properties positively affecting the performances and therapeutic profiles of drugs.

    Besides, a drug–CD complex with the addition of an auxiliary substance, that are called multicomponent or ternary complex, can have a synergic effect, allowing the use of low concentrations of the host compounds, thereby optimizing the cost, toxicity and formulation volume in the final product. Also, these additives such as amino acids, organic acids and bases, and water-soluble polymers interacting with CDs can modulate in vitro and in vivo drug dissolution, thereby modifying the drug’s pharmacokinetic profile.

    1. Amino Acids as Auxiliary Agents

    Amino acids (AAs) present a series of adequate properties for pharmaceutical applications, so they are generally regarded as safe and have great potential for interacting with CDs and drugs via hydrogen bonding with CDs and via electrostatic interactions and salt formation with drugs. Several examples of multicomponent complexes of CD can be found in the literature in which AAs have been used as auxiliary agents not only to improve the solubility and dissolution rates of poorly soluble drugs, but also to allow the modulation of other drug properties. For example, AAs have shown their usefulness by increasing antimicrobial activity and reducing the toxicity of drugs. Among the AAs that have been used to prepare multicomponent complexes, it is possible to mention glycine, cysteine, proline, arginine, lysine, aspartic acid and glutamic acid, being arginine one of the AAs that has produced the best results in the formation of multicomponent complexes. Table 1 shows some reports on ternary complexes of CDs with arginine, incorporating the improvements in the pharmaceutical properties achieved.

    Table 1. Summary of some reports on ternary complexes of CDs with arginine, including the improvements in pharmaceutical properties.

    Ternary System Solubility Dissolution Reference
    naproxen-HPβCD-arginine synergistic action between HPβCD and arginine with 13-fold solubility increment superior performance of coevaporate complex with 15 times increase in DE [1][2]
    lornoxicam-βCD-arginine freeze-dried complex showed the higher solubility saturation in different buffer media

    freeze-dried complexes exhibits >95% dissolution after 20 min

    [3]
    etodolac-HPβCD-arginine Spray-dried and coevaporate ternary complex showed an increment of 163- and 100-fold, respectively, in water with respect to saturation solubility of pure drug Spray-dried and coevaporate ternary complex exhibits an increase in percent drug release of 19- and 20-fold, respectively, with respect to pure etodolac. [4]
    glyburide-HPβCD-arginine

     

    ternary complex showed higher solubility in both aqueous media and buffer pH 7.5

    ternary complex exhibits significant improvement in the dissolution profile compared with the pure drug in unbuffered aqueous media

    [5]

    cefixime-βCD-arginine

    cefixime-HPβCD-arginine
    ternary complex showed better drug solubility ternary complex with HPβCD exhibit better performance (DE2 = 25) compared with the drug alone (DE2 = 0.75) [6]
    rifampicin-βCD- arginine ternary complex showed an increase in the drug solubility

    ternary complex showed an increase in the dissolved percentage of the drug (53% versus 25% for drug alone)

    [7]

    2. Organic Acids as Auxiliary Agents

    Multicomponent complexes with CDs and different acids have been studied to improve the properties by orders of magnitude of basic drugs in relation to classic drug–CD binary complexes. The auxiliary acid substances, together with the CDs, improve the physicochemical, chemical and transport properties of drugs, and therefore provide advantages in terms of bioavailability and pharmaceutical use. The mechanism of action of weak acids allows stabilizing a ternary complex through a combination of interactions (hydrogen bonding, salt formation and electrostatic interactions) depending on the nature and structural characteristics of the molecules. Among the hydroxy acids, the citric, gluconic, tartaric, lactic and malic acids are reported to be promising ternary candidates due to their potential ability to interact with CD molecules by forming hydrogen bonds with their numerous hydroxyl groups, and in Table 2 are shown some results obtained with ternary complexes of CDs and citric acid (CA).

    Ternary System Solubility

    Dissolution

    Other Properties Reference
    Econazole nitrate-SBEβCD-CA synergistic action between SBEβCD and CA with 21.2 fold solubility increment superior performance of co-ground system concentration increased to 479.07 ± 11.3 mg/mL after 45 min higher antimycotic activity with respect to that of pure Econazole [8][9]
    Carvedilol-βCD-CA spray-dried complex exhibits the higher solubility saturation in different buffer media spray-dried complex exhibits significant improvement in the dissolution profile compared with the pure carvedilol spray-dried complex is stable in exposition to 40 °C at 75% relative humidity [10]

    Clarithromycin-βCD-CA

      freeze-dried complex exhibits rapid and enhanced dissolution rate in basic media freeze-dried complex exhibits slightly improved absorption in beagle dogs [11]
    Ketoconazole-βCD-CA   spray-dried complex reach a dissolution percentage close to 100%   [12]

    3. Organic Bases as Auxiliary Agents

    Organic bases, whose structural diversity predetermines their magnitudes of effect upon drug–CD solution interactions, are being employed as tertiary components in ternary complexes, and they are used mainly when the drugs are acids. In these systems, the prominent role of electrostatic forces in the general interaction should be considered. Although the CD complexes obtained from non-ionized drugs have greater stability compared with their anionic analogues, the total solubility achieved and other properties of the drug such as chemical stability and bioavailability usually improve. Ternary systems with ethanolamines (monoethanolamine, diethanolamine and triethanolamine) improved the physicochemical properties of drugs, such as solubility and permeability through the cornea and duodenal epithelium, as well as increased therapeutic performance and decreased drug toxicity, as reported for acetazolamide [13][14].

    Water-soluble polymers are known to interact with the outer surfaces of CD and drug–CD complexes, forming aggregates or co-complexes that show values of stability constants constant higher than those of binary drug–CD systems. They can also increase the solubility of complexes and decrease CD mobility by changing the hydration properties of CD molecules. Polymers such as Polyvinylpyrrolidone, Chitosan, Hydroxypropylmethylcellulose, Hyaluronic Acid, Polyethylene Glycol, Poloxamer, demonstrated enhancement of solubilization and permeation through biological membranes by means of the formation of multicomponent complexes with CDs. Also, it was evaluated the anti-tumor effects in vitro and in vivo of a multicomponent system of β-lapachone, MβCD, and poloxamer and it was demonstrated  a significantly decreased in the tumor volume while increasing apoptosis and DNA damage without evident toxicity to the liver or kidneys [15][16] .

    References

    1. Paola Mura; Ternary systems of naproxen with hydroxypropyl-β-cyclodextrin and aminoacids. International Journal of Pharmaceutics 2003, 260, 293-302, 10.1016/s0378-5173(03)00265-5.
    2. Paola Mura; Gian Piero Bettinetti; Marzia Cirri; Francesca Maestrelli; Milena Sorrenti; Laura Catenacci; Solid-state characterization and dissolution properties of Naproxen–Arginine–Hydroxypropyl-β-cyclodextrin ternary system. European Journal of Pharmaceutics and Biopharmaceutics 2005, 59, 99-106, 10.1016/j.ejpb.2004.05.005.
    3. D. M. Bramhane; N. S. Saindane; P. R. Vavia; Inclusion complexation of weakly acidic NSAID with β-cyclodextrin: selection of arginine, an amino acid, as a novel ternary component. Journal of Inclusion Phenomena and Macrocyclic Chemistry 2010, 69, 453-460, 10.1007/s10847-010-9783-7.
    4. Atul P. Sherje; Vaidehi Kulkarni; Manikanta Murahari; Usha Y. Nayak; Pritesh Bhat; Vasanti Suvarna; Bhushan Dravyakar; Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies. Molecular Pharmaceutics 2017, 14, 1231-1242, 10.1021/acs.molpharmaceut.6b01115.
    5. Sachin Kumar Singh; K. K. Srinivasan; Dhananjay S. Singare; K. Gowthamarajan; Dev Prakash; Formulation of ternary complexes of glyburide with hydroxypropyl-β-cyclodextrin and other solubilizing agents and their effect on release behavior of glyburide in aqueous and buffered media at different agitation speeds. Drug Development and Industrial Pharmacy 2012, 38, 1328-1336, 10.3109/03639045.2011.650645.
    6. Priyanka Jadhav; Bhushan Petkar; Yogesh Pore; Anita Kulkarni; Kishorkumar Burade; Physicochemical and molecular modeling studies of cefixime–l-arginine–cyclodextrin ternary inclusion compounds. Carbohydrate Polymers 2013, 98, 1317-1325, 10.1016/j.carbpol.2013.07.070.
    7. Antonella V. Dan Córdoba; Virginia Aiassa; Marcela R. Longhi; Mario A. Quevedo; Ariana Zoppi; Improved Activity of Rifampicin Against Biofilms of Staphylococcus aureus by Multicomponent Complexation. AAPS PharmSciTech 2020, 21, 1-13, 10.1208/s12249-020-01706-z.
    8. Mario Jug; Natascia Mennini; Katalin E. Kövér; Paola Mura; Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state. Journal of Pharmaceutical and Biomedical Analysis 2014, 91, 81-91, 10.1016/j.jpba.2013.12.029.
    9. Paola Mura; Natascia Mennini; Ivan Kosalec; Sandra Furlanetto; Serena Orlandini; Mario Jug; Amidated pectin-based wafers for econazole buccal delivery: Formulation optimization and antimicrobial efficacy estimation. Carbohydrate Polymers 2015, 121, 231-240, 10.1016/j.carbpol.2014.11.065.
    10. Varsha Pokharkar; Abhishek Khanna; Vinod Venkatpurwar; Sheetal Dhar; Leenata Mandpe; Ternary complexation of carvedilol, β-cyclodextrin and citric acid for mouth-dissolving tablet formulation. Acta Pharmaceutica 2008, 59, 121-32, 10.2478/v10007-009-0001-3.
    11. Xiangrong Zhang; Meijuan Zou; Sanming Li; Xiaoyan Chen; Dafang Zhong; Bioavailability of Clarithromycin Cyclodextrin Ternary Complexes Upon Oral Administration to Healthy Beagle Dogs. Drug Development and Industrial Pharmacy 2007, 34, 1048-1053, 10.1080/03639040801937474.
    12. M Esclusa-Diaz; M. Gayo-Otero; M.B. Pérez-Marcos; J.L. Vila-Jato; J.J. Torres-Labandeira; Preparation and evaluation of ketoconazole-β-cyclodextrin multicomponent complexes. International Journal of Pharmaceutics 1996, 142, 183-187, 10.1016/0378-5173(96)04666-2.
    13. Santiago D. Palma; Luis I. Tártara; Daniela Quinteros; Daniel A. Allemandi; Marcela R. Longhi; Gladys E. Granero; An efficient ternary complex of acetazolamide with HP-ß-CD and TEA for topical ocular administration. Journal of Controlled Release 2009, 138, 24-31, 10.1016/j.jconrel.2009.04.035.
    14. María J. Mora; Juan P. Petiti; Marcela R. Longhi; Alicia I. Torres; Gladys E. Granero; Intestinal uptake and toxicity evaluation of acetazolamide and its multicomponent complexes with hidroxypropyl-β-cyclodextrin in rats. International Journal of Pharmaceutics 2014, 478, 258-267, 10.1016/j.ijpharm.2014.11.027.
    15. Norased Nasongkla; Andy F. Wiedmann; Andrew Bruening; Meghan Beman; Dale Ray; William G. Bornmann; David A. Boothman; Jinming Gao; Enhancement of Solubility and Bioavailability of β-Lapachone Using Cyclodextrin Inclusion Complexes. Pharmaceutical Research 2002, 20, 1626-1633, 10.1023/a:1026143519395.
    16. Samuel Seoane; Patricia Díaz-Rodríguez; Juan Sendon-Lago; Rosalia Gallego; Roman Perez-Fernandez; Mariana Landin; Administration of the optimized β-Lapachone–poloxamer–cyclodextrin ternary system induces apoptosis, DNA damage and reduces tumor growth in a human breast adenocarcinoma xenograft mouse model. European Journal of Pharmaceutics and Biopharmaceutics 2013, 84, 497-504, 10.1016/j.ejpb.2012.12.019.
    More